$92.09
-1.72-1.83%
At Close: -
$91.50
-0.59-0.64%
After Hours: Jul 19, 7:19 PM EDT
15 minutes delayed
Comments
Loading...
Albemarle
ALBNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Albemarle (NYSE:ALB) Stock, Analyst Ratings, Price Targets, Forecasts
Albemarle Corp has a consensus price target of $152.88 based on the ratings of 25 analysts. The high is $295 issued by Citigroup on December 15, 2022. The low is $81 issued by Morgan Stanley on March 11, 2024. The 3 most-recent analyst ratings were released by HSBC, Citigroup, and Wells Fargo on July 17, 2024, July 12, 2024, and July 11, 2024, respectively. With an average price target of $98.33 between HSBC, Citigroup, and Wells Fargo, there's an implied 7.47% upside for Albemarle Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HSBC
Citigroup
Wells Fargo
Keybanc
UBS
1calculated from analyst ratings
Analyst Ratings for Albemarle
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/17/2024 | Buy Now | 3.83% | HSBC | Santhosh Seshadri | → $95 | Downgrade | Buy → Hold | Get Alert |
| 07/12/2024 | Buy Now | 9.29% | Citigroup | Patrick Cunningham | $137 → $100 | Maintains | Neutral | Get Alert |
| 07/11/2024 | Buy Now | 9.29% | Wells Fargo | Michael Sison | $145 → $100 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/10/2024 | Buy Now | 65.03% | Keybanc | Aleksey Yefremov | — | Maintains | Overweight | Get Alert |
| 07/09/2024 | Buy Now | 19.13% | UBS | Joshua Spector | $124 → $109 | Maintains | Neutral | Get Alert |
| 07/09/2024 | Buy Now | 94.54% | Oppenheimer | Colin Rusch | $188 → $178 | Maintains | Outperform | Get Alert |
| 07/09/2024 | Buy Now | 38.8% | Baird | Ben Kallo | $170 → $127 | Maintains | Outperform | Get Alert |
| 06/25/2024 | Buy Now | 3.83% | Piper Sandler | Charles Neivert | $122 → $95 | Maintains | Underweight | Get Alert |
| 06/13/2024 | Buy Now | 35.52% | UBS | Joshua Spector | $132 → $124 | Maintains | Neutral | Get Alert |
| 05/24/2024 | Buy Now | 71.58% | RBC Capital | Arun Viswanathan | → $157 | Reiterates | Outperform → Outperform | Get Alert |
| 05/21/2024 | Buy Now | 47.54% | Scotiabank | Ben Isaacson | $150 → $135 | Downgrade | Sector Outperform → Sector Perform | Get Alert |
| 05/07/2024 | Buy Now | 53.01% | Deutsche Bank | Corinne Blanchard | $125 → $140 | Maintains | Hold | Get Alert |
| 05/06/2024 | Buy Now | 63.93% | Scotiabank | Ben Isaacson | $160 → $150 | Maintains | Sector Outperform | Get Alert |
| 05/06/2024 | Buy Now | 71.58% | RBC Capital | Arun Viswanathan | $138 → $157 | Maintains | Outperform | Get Alert |
| 05/02/2024 | Buy Now | 39.89% | Mizuho | John Roberts | $112 → $128 | Maintains | Neutral | Get Alert |
| 04/11/2024 | Buy Now | 58.47% | Wells Fargo | Michael Sison | $135 → $145 | Maintains | Overweight | Get Alert |
| 04/11/2024 | Buy Now | 74.86% | Berenberg | Andres Castanos Mollor | $130 → $160 | Upgrade | Hold → Buy | Get Alert |
| 04/10/2024 | Buy Now | 47.54% | Citigroup | Patrick Cunningham | $125 → $135 | Maintains | Neutral | Get Alert |
| 04/10/2024 | Buy Now | 70.49% | B of A Securities | Matthew DeYoe | $137 → $156 | Upgrade | Neutral → Buy | Get Alert |
| 03/15/2024 | Buy Now | 77.05% | Loop Capital | Christopher Kapsch | $168 → $162 | Maintains | Buy | Get Alert |
| 03/11/2024 | Buy Now | -11.48% | Morgan Stanley | Vincent Andrews | $90 → $81 | Maintains | Underweight | Get Alert |
| 03/08/2024 | Buy Now | 58.47% | Vertical Research | Kevin McCarthy | → $145 | Downgrade | Buy → Hold | Get Alert |
| 03/07/2024 | Buy Now | 22.4% | Mizuho | John Roberts | $115 → $112 | Maintains | Neutral | Get Alert |
| 03/07/2024 | Buy Now | 73.77% | Keybanc | Aleksey Yefremov | $178 → $159 | Maintains | Overweight | Get Alert |
| 03/01/2024 | Buy Now | — | Wolfe Research | Chris Parkinson | — | Initiates | → Peer Perform | Get Alert |
| 02/27/2024 | Buy Now | 25.68% | Mizuho | John Roberts | $105 → $115 | Maintains | Neutral | Get Alert |
| 02/16/2024 | Buy Now | 47.54% | Wells Fargo | Michael Sison | $140 → $135 | Maintains | Overweight | Get Alert |
| 02/16/2024 | Buy Now | 50.82% | RBC Capital | Arun Viswanathan | $140 → $138 | Maintains | Outperform | Get Alert |
| 02/16/2024 | Buy Now | 105.46% | Oppenheimer | Colin Rusch | $191 → $188 | Maintains | Outperform | Get Alert |
| 02/16/2024 | Buy Now | 94.54% | Keybanc | Aleksey Yefremov | $199 → $178 | Maintains | Overweight | Get Alert |
| 02/15/2024 | Buy Now | 36.61% | UBS | Joshua Spector | $137 → $125 | Maintains | Neutral | Get Alert |
| 02/09/2024 | Buy Now | 31.15% | Citigroup | Patrick Cunningham | $175 → $120 | Downgrade | Buy → Neutral | Get Alert |
| 01/30/2024 | Buy Now | 49.73% | UBS | Joshua Spector | $142 → $137 | Maintains | Neutral | Get Alert |
| 01/29/2024 | Buy Now | 42.08% | TD Cowen | David Deckelbaum | → $130 | Downgrade | Outperform → Market Perform | Get Alert |
| 01/23/2024 | Buy Now | 42.08% | Mizuho | Christopher Parkinson | $152 → $130 | Maintains | Neutral | Get Alert |
| 01/17/2024 | Buy Now | 108.74% | Oppenheimer | Colin Rusch | $308 → $191 | Maintains | Outperform | Get Alert |
| 01/11/2024 | Buy Now | 55.19% | UBS | Joshua Spector | $130 → $142 | Maintains | Neutral | Get Alert |
| 01/11/2024 | Buy Now | 47.54% | Deutsche Bank | Corinne Blanchard | $155 → $135 | Downgrade | Buy → Hold | Get Alert |
| 01/09/2024 | Buy Now | 117.49% | Keybanc | Aleksey Yefremov | $200 → $199 | Maintains | Overweight | Get Alert |
| 12/21/2023 | Buy Now | 91.26% | Citigroup | Patrick Cunningham | $170 → $175 | Maintains | Buy | Get Alert |
| 12/12/2023 | Buy Now | 62.84% | B of A Securities | Matthew DeYoe | $154 → $149 | Upgrade | Underperform → Neutral | Get Alert |
| 12/05/2023 | Buy Now | 39.89% | Piper Sandler | Charles Neivert | $140 → $128 | Downgrade | Neutral → Underweight | Get Alert |
| 11/07/2023 | Buy Now | 96.72% | BMO Capital | Joel Jackson | $265 → $180 | Maintains | Outperform | Get Alert |
| 11/06/2023 | Buy Now | 78.14% | RBC Capital | Arun Viswanathan | $212 → $163 | Maintains | Outperform | Get Alert |
| 11/06/2023 | Buy Now | 53.01% | UBS | Joshua Spector | $253 → $140 | Downgrade | Buy → Neutral | Get Alert |
| 11/03/2023 | Buy Now | 236.61% | Oppenheimer | Colin Rusch | $344 → $308 | Maintains | Outperform | Get Alert |
| 11/03/2023 | Buy Now | 118.58% | Keybanc | Aleksey Yefremov | $254 → $200 | Maintains | Overweight | Get Alert |
| 10/25/2023 | Buy Now | 69.4% | Piper Sandler | Charles Neivert | $255 → $155 | Downgrade | Overweight → Neutral | Get Alert |
| 10/18/2023 | Buy Now | 75.96% | B of A Securities | Matthew DeYoe | $212 → $161 | Downgrade | Neutral → Underperform | Get Alert |
| 10/09/2023 | Buy Now | 184.15% | RBC Capital | Arun Viswanathan | → $260 | Reiterates | Outperform → Outperform | Get Alert |
| 10/09/2023 | Buy Now | 129.51% | Wells Fargo | Michael Sison | $260 → $210 | Maintains | Overweight | Get Alert |
| 10/04/2023 | Buy Now | 134.97% | Citigroup | Patrick Cunningham | $265 → $215 | Maintains | Buy | Get Alert |
| 10/03/2023 | Buy Now | 177.6% | Keybanc | Aleksey Yefremov | $291 → $254 | Maintains | Overweight | Get Alert |
| 09/08/2023 | Buy Now | 206.01% | Evercore ISI Group | Stephen Richardson | $295 → $280 | Maintains | Outperform | Get Alert |
| 09/01/2023 | Buy Now | 178.69% | Piper Sandler | Charles Neivert | $275 → $255 | Maintains | Overweight | Get Alert |
| 08/08/2023 | Buy Now | 184.15% | RBC Capital | Arun Viswanathan | $255 → $260 | Maintains | Outperform | Get Alert |
| 08/07/2023 | Buy Now | 173.22% | Deutsche Bank | David Begleiter | $260 → $250 | Maintains | Buy | Get Alert |
| 08/04/2023 | Buy Now | 131.69% | B of A Securities | Matthew DeYoe | $200 → $212 | Maintains | Neutral | Get Alert |
| 08/04/2023 | Buy Now | 184.15% | Wells Fargo | Michael Sison | $270 → $260 | Maintains | Overweight | Get Alert |
| 08/04/2023 | Buy Now | 148.09% | Mizuho | Christopher Parkinson | $225 → $227 | Maintains | Neutral | Get Alert |
| 08/03/2023 | Buy Now | 102.19% | Credit Suisse | John Roberts | $163 → $185 | Maintains | Underperform | Get Alert |
| 07/18/2023 | Buy Now | 195.08% | Wells Fargo | Michael Sison | $250 → $270 | Maintains | Overweight | Get Alert |
| 07/17/2023 | Buy Now | 69.4% | Morgan Stanley | Vincent Andrews | $155 → $155 | Reiterates | Underweight → Underweight | Get Alert |
| 06/26/2023 | Buy Now | 218.03% | Keybanc | Aleksey Yefremov | $270 → $291 | Maintains | Overweight | Get Alert |
| 06/14/2023 | Buy Now | 184.15% | Citigroup | Patrick Cunningham | → $260 | Initiates | → Buy | Get Alert |
| 05/18/2023 | Buy Now | 145.9% | UBS | Joshua Spector | $196 → $225 | Upgrade | Neutral → Buy | Get Alert |
| 05/15/2023 | Buy Now | 214.75% | Baird | Ben Kallo | $222 → $288 | Upgrade | Neutral → Outperform | Get Alert |
| 05/11/2023 | Buy Now | 195.08% | Keybanc | Aleksey Yefremov | → $270 | Upgrade | Sector Weight → Overweight | Get Alert |
| 05/10/2023 | Buy Now | 173.22% | Scotiabank | Ben Isaacson | $315 → $250 | Upgrade | Sector Perform → Sector Outperform | Get Alert |
| 05/09/2023 | Buy Now | 173.22% | Scotiabank | Ben Isaacson | → $250 | Upgrade | Sector Perform → Sector Outperform | Get Alert |
| 05/08/2023 | Buy Now | 118.58% | B of A Securities | Matthew DeYoe | $195 → $200 | Upgrade | Underperform → Neutral | Get Alert |
| 05/08/2023 | Buy Now | 178.69% | RBC Capital | Arun Viswanathan | $309 → $255 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 227.87% | BMO Capital | Joel Jackson | $325 → $300 | Maintains | Outperform | Get Alert |
| 05/05/2023 | Buy Now | 173.22% | Wells Fargo | Michael Sison | $277 → $250 | Maintains | Overweight | Get Alert |
| 05/05/2023 | Buy Now | 145.9% | Mizuho | Christopher Parkinson | $224 → $225 | Maintains | Neutral | Get Alert |
| 05/04/2023 | Buy Now | 227.87% | TD Cowen | David Deckelbaum | $330 → $300 | Maintains | Outperform | Get Alert |
| 05/02/2023 | Buy Now | 144.81% | Mizuho | Christopher Parkinson | $328 → $224 | Maintains | Neutral | Get Alert |
| 04/20/2023 | Buy Now | 162.3% | Deutsche Bank | David Begleiter | $325 → $240 | Maintains | Buy | Get Alert |
| 04/17/2023 | Buy Now | 145.9% | Berenberg | Andres Castanos Mollor | $290 → $225 | Maintains | Hold | Get Alert |
| 04/10/2023 | Buy Now | 202.73% | Wells Fargo | Michael Sison | $350 → $277 | Maintains | Overweight | Get Alert |
| 04/06/2023 | Buy Now | 202.73% | Wells Fargo | Michael Sison | $350 → $277 | Maintains | Overweight | Get Alert |
| 04/05/2023 | Buy Now | 113.11% | B of A Securities | Matthew DeYoe | $262 → $195 | Downgrade | Neutral → Underperform | Get Alert |
| 02/21/2023 | Buy Now | 444.26% | Oppenheimer | Colin Rusch | $497 → $498 | Maintains | Outperform | Get Alert |
| 02/21/2023 | Buy Now | 260.66% | Piper Sandler | Charles Neivert | $310 → $330 | Maintains | Overweight | Get Alert |
| 02/17/2023 | Buy Now | 444.26% | Oppenheimer | Colin Rusch | $497 → $498 | Maintains | Outperform | Get Alert |
| 02/17/2023 | Buy Now | 258.47% | Mizuho | Christopher Parkinson | $325 → $328 | Maintains | Neutral | Get Alert |
| 02/17/2023 | Buy Now | 255.19% | BMO Capital | Joel Jackson | $315 → $325 | Maintains | Outperform | Get Alert |
| 02/16/2023 | Buy Now | 162.3% | Credit Suisse | John Roberts | → $240 | Reiterates | → Underperform | Get Alert |
| 01/31/2023 | Buy Now | 162.3% | Credit Suisse | John Roberts | $200 → $240 | Maintains | Underperform | Get Alert |
| 01/26/2023 | Buy Now | 255.19% | Mizuho | Christopher Parkinson | $300 → $325 | Maintains | Neutral | Get Alert |
| 01/26/2023 | Buy Now | 238.8% | Piper Sandler | Charles Neivert | → $310 | Initiates | → Overweight | Get Alert |
| 01/25/2023 | Buy Now | 295.63% | RBC Capital | Arun Viswanathan | $340 → $362 | Maintains | Outperform | Get Alert |
| 01/25/2023 | Buy Now | 233.33% | Deutsche Bank | David Begleiter | $290 → $305 | Maintains | Buy | Get Alert |
| 01/25/2023 | Buy Now | 233.33% | Baird | Ben Kallo | $298 → $305 | Maintains | Neutral | Get Alert |
| 01/25/2023 | Buy Now | 443.17% | Oppenheimer | Colin Rusch | $461 → $497 | Maintains | Outperform | Get Alert |
| 01/12/2023 | Buy Now | 227.87% | Mizuho | Christopher Parkinson | $325 → $300 | Maintains | Neutral | Get Alert |
| 01/11/2023 | Buy Now | 173.22% | UBS | Joshua Spector | $297 → $250 | Maintains | Neutral | Get Alert |
| 01/10/2023 | Buy Now | 216.94% | Deutsche Bank | David Begleiter | $325 → $290 | Maintains | Buy | Get Alert |
| 12/15/2022 | Buy Now | 222.4% | Citigroup | PJ Juvekar | $345 → $295 | Maintains | Buy | Get Alert |
| 11/28/2022 | Buy Now | 69.4% | Morgan Stanley | Vincent Andrews | $145 → $155 | Maintains | Underweight | Get Alert |
FAQ
What is the target price for Albemarle (ALB) stock?
The latest price target for Albemarle (NYSE:ALB) was reported by HSBC on July 17, 2024. The analyst firm set a price target for $95.00 expecting ALB to rise to within 12 months (a possible 3.83% upside). 61 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Albemarle (ALB)?
The latest analyst rating for Albemarle (NYSE:ALB) was provided by HSBC, and Albemarle downgraded their hold rating.
When was the last upgrade for Albemarle (ALB)?
The last upgrade for Albemarle Corp happened on April 11, 2024 when Berenberg raised their price target to $160. Berenberg previously had a hold for Albemarle Corp.
When was the last downgrade for Albemarle (ALB)?
The last downgrade for Albemarle Corp happened on July 17, 2024 when HSBC changed their price target from N/A to $95 for Albemarle Corp.
When is the next analyst rating going to be posted or updated for Albemarle (ALB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Albemarle, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Albemarle was filed on July 17, 2024 so you should expect the next rating to be made available sometime around July 17, 2025.
Is the Analyst Rating Albemarle (ALB) correct?
While ratings are subjective and will change, the latest Albemarle (ALB) rating was a downgraded with a price target of $0.00 to $95.00. The current price Albemarle (ALB) is trading at is $91.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.